NETHERTON SYNDROME
Clinical trials for NETHERTON SYNDROME explained in plain language.
Never miss a new study
Get alerted when new NETHERTON SYNDROME trials appear
Sign up with your email to follow new studies for NETHERTON SYNDROME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New cream shows promise for rare skin disease
Disease control CompletedThis study tested a cream called SXR1096 on 9 people with Netherton syndrome, a rare genetic skin condition that causes redness, scaling, and itching. The cream aims to block certain enzymes that drive the disease. Participants applied the cream to some skin areas and a placebo t…
Matched conditions: NETHERTON SYNDROME
Phase: PHASE1, PHASE2 • Sponsor: Sixera Pharma • Aim: Disease control
Last updated May 26, 2026 11:38 UTC
-
Could a common arthritis drug ease rare skin disease?
Disease control CompletedThis study tested the drug Humira (adalimumab) in 11 people with Netherton syndrome, a rare genetic skin condition that causes severe inflammation, itching, and pain. The goal was to see if Humira could reduce skin symptoms after 3 months of treatment, with a 3-month follow-up. W…
Matched conditions: NETHERTON SYNDROME
Phase: PHASE2 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated May 26, 2026 11:34 UTC
-
Scientists map rare skin disease to unlock future treatments
Knowledge-focused CompletedThis study followed 18 people with Netherton syndrome, a rare genetic skin disorder, to learn how the disease affects the body over time. Researchers measured immune system markers and skin changes to better understand the condition. No new treatments were tested; the goal was to…
Matched conditions: NETHERTON SYNDROME
Phase: NA • Sponsor: Institut National de la Santé Et de la Recherche Médicale, France • Aim: Knowledge-focused
Last updated May 26, 2026 11:31 UTC